EUVIMEDEUVIMED entdecken
Leserbrief

Comment on ‘The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment’

Wenxiang Zhang, Baorui Ren iD

British Journal of Clinical Pharmacology · 11.11.2026

DOI: 10.1002/bcp.70920 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 11.11.2026. Verfasst von Wenxiang Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Baorui Ren

Zitieren

APA

Zhang, W., & Ren, B. (2026). Comment on ‘The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment’. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70920

Vancouver

Zhang W, Ren B. Comment on ‘The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment’. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70920

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenxiang and Ren, Baorui},
  title = {Comment on ‘The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment’},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70920}
}
Kostenlos starten →